Curcumin-based nanoformulations as an emerging therapeutic strategy for inflammatory lung diseases

Future Med Chem. 2023 Apr;15(7):583-586. doi: 10.4155/fmc-2023-0048. Epub 2023 May 4.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Curcumin* / pharmacology
  • Curcumin* / therapeutic use
  • Drug Delivery Systems
  • Humans
  • Lung Diseases* / drug therapy

Substances

  • Curcumin